ARTICLE | Clinical News
Pollinex Quattro Ragweed: Phase III data
September 29, 2008 7:00 AM UTC
The North American Phase III R301 trial showed that Pollinex Quattro Ragweed vaccine met the primary endpoint of difference in combined symptom/medication score vs. placebo over the 4 peak pollen week...